Bank of America
DRUG

Bank of America’s Bright Minds Biosciences DRUG Stock Holding History

Bank of America’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
19,422
+4,347
+29% +$350K ﹤0.01% 4319
2025
Q4 		$1.18M Buy
15,075
+8,038
+114% +$537K ﹤0.01% 4423
2025
Q3 		$427K Buy
7,037
+2,303
+49% +$89.4K ﹤0.01% 5888
2025
Q2 		$124K Sell
4,734
-682
-13% -$20.4K ﹤0.01% 6422
2025
Q1 		$195K Buy
5,416
+623
+13% +$22.8K ﹤0.01% 6186
2024
Q4 		$173K Buy
+4,793
New +$169K ﹤0.01% 6178
2022
Q4 		– Sell
-2,131
Closed -$13K – 8255
2022
Q3 		$13K Buy
+2,131
New +$13.8K ﹤0.01% 7161

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Bank of America's DRUG Position: Q1 2026 in Review

Bank of America increased its Bright Minds Biosciences (DRUG) stake by 29% in Q1 2026, buying an estimated $350K and bringing the position to 19,422 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4319.

Bank of America first reported a position in DRUG in Q3 2022 and has held it in 7 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Bank of America held 19,422 shares of Bright Minds Biosciences worth $1.42M as of Q1 2026.
  • Bank of America bought 4,347 Bright Minds Biosciences shares in Q1 2026, an estimated $350K.
  • Bright Minds Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4319 holding.
  • Bank of America first reported a position in Bright Minds Biosciences in Q3 2022 and has held it in 7 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.